Interestingly, Chen et al. found that in patients with metastatic melanoma, the level of circulating exosomal PD-L1 correlates to that of serum IFN-γ and that exosomes derived from melanoma cells treated with IFN-γ exhibited enhanced binding to PD-1 in vitro [12]. This evidence concerns the gene IFNG and metastatic melanoma.